Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 23,850,000 | 24,197,700 | 22,636,000 | 22,011,900 | 22,972,800 |
| Cost of Goods | 5,583,000 | 6,140,700 | 6,001,100 | 5,149,600 | 4,965,700 |
| Gross Profit | 18,267,000 | 18,057,000 | 16,634,900 | 16,862,300 | 18,007,100 |
| Operating Expenses | 12,182,000 | 12,440,200 | 12,948,400 | 11,004,100 | 11,249,600 |
| Operating Income | 6,085,000 | 5,617,500 | 3,686,600 | 5,858,801 | 6,758,200 |
| Other Income | 3,846,000 | -2,125,400 | 2,534,800 | 1,505,099 | 1,244,600 |
| Pre-tax Income | 9,931,000 | 3,492,100 | 6,221,400 | 7,363,900 | 8,002,800 |
| Income Tax | 1,999,000 | 95,300 | 1,787,600 | 2,732,600 | 2,172,700 |
| Net Income Continuous | 7,932,000 | 3,396,800 | 4,433,800 | 4,631,300 | 5,830,100 |
| Minority Interests | 124,000 | 121,400 | N/A | N/A | N/A |
| Net Income | $7,808,000 | $3,275,400 | $4,433,800 | $4,631,300 | $5,830,100 |
| EPS Basic Total Ops | 3.65 | 1.51 | 2.04 | 2.11 | 2.63 |
| EPS Basic Continuous Ops | 3.71 | 1.57 | 2.04 | 2.11 | 2.63 |
| EPS Diluted Total Ops | 3.63 | 1.49 | 2.03 | 2.10 | 2.62 |
| EPS Diluted Continuous Ops | 3.70 | 1.55 | 2.03 | 2.10 | 2.62 |
| EBITDA(a) | $7,716,000 | $7,605,700 | $5,955,000 | $7,566,901 | $8,208,900 |